TP53 codon 72 polymorphism and gastric cancer risk: A case-control study in individuals from the central-western region of Venezuela;Polimorfismo del codón 72 de TP53 y riesgo de cáncer gástrico: Estudio caso-control en individuos de la región centroccidental de Venezuela

Investigacion Clinica

Volumn 50, Issue 2, 2009, Pages 153-161

  Cañas, Miryan ^a   Morán, Yeinmy ^a   Camargo, María Eugenia ^a   Rivero, María Belén ^a   Bohórquez, Adolfo ^b   Villegas, Venus ^b   Ramírez, Eddy ^b   Rendón, Yanet ^b   Suárez, Alfredo ^b   Morales, Luis ^b   Useche, Emerson ^b   Salazar, Sandra ^b   Zambrano, Amado ^b   Ramírez, Álvaro ^b   Valderrama, Elvis ^c   Briceño, Zuly ^d   Chiurillo, Miguel Ángel ^a  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^b Servicio de Gastroenterología Hospital Antonio María Pineda UCLA   (Venezuela)

^c Departamento de Anatomía Patológica HAMP UCLA   (Venezuela)

^d UCLA Decanato de Ciencias y Tecnología   (Venezuela)

Author keywords

Gastric cancer; Genetic polymorphism; TP53 codon 72

Indexed keywords

ARGININE; PROLINE; PROTEIN P53; DNA;

ARTICLE; CANCER RISK; CHRONIC GASTRITIS; CODON; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; ENDOSCOPIC BIOPSY; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; VENEZUELA; ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ALLELE; CASE CONTROL STUDY; CELL DIFFERENTIATION; FEMALE; GASTRITIS; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CODON; DNA, NEOPLASM; FEMALE; GASTRITIS; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; STOMACH NEOPLASMS; VENEZUELA; YOUNG ADULT;

EID: 70349579122     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Parkin M, Bray F, Devesa S. Cancer burden in the year 2000. The global picture. Europ J Cancer 2001; 37:S4-S66.
2. Devesa SS, Fraumeni JF Jr. The rising incidence of gastric cardia cancer. J Natl Cancer Inst 1999; 91:747-749.
3. Stadtlander CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999; 20:2195-2208.
4. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993; 119:265-272.
5. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in human cancers. Science 1991; 253:49-53.
6. Levine AJ. p53, The cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
7. Pinto GR, Yoshioka FKN, Silva RLL, Clara CA, Santos MJ, Almeida JRW, Burbano RR, Rey JA, Casartelli C. Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genet Mol Res 2008; 7:207-216.
8. Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, DeVoe G, Miller MA, Wang J, Noffsinger A, Fenoglio-Preiser C. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology 2000; 118:1039-1044.
9. Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, Shimamoto F, Haruma K, Chayama K. p53 codon polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 2002; 100: 304-308.
10. Sul J, Yu GP, Lu QY, Lu ML, Setiawan VW, Wang MR, Guo CH, Yu SZ, Mu L, Cai L, Kurtz RC, Zhang ZF. p53 codon 72 polymorphisms: A case-control study of gastric cancer and potential interactions. Cancer Letters 2006; 238:210-223. (Pubitemid 43884957)
11. Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, Farthing M, Alderson D, Holly J. Age-associated increase of codon 72 arginine p53 frecuency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 2003; 9:2151-2156. (Pubitemid 36687637)
12. Zhang ZW, Laurence N, Hollowood A, Newcomb P, Moorghen M, Gupta J, Feakins R, Farthing M, Alderson D, Holly J. Prognostic value of TP53 codon 72 polymorphism in advanced gastric adenocarcinoma. Clin Cancer Res 2004; 10:131-135. (Pubitemid 38114171)
13. Wang YC, Chen CY, Chen SK, Chang YY, Lin P. p53 codon 72 polymorphism in Taiwanese lung cancer patients: Association with lung cancer susceptibility and prognosis. Clin Cancer Res 1999; 5:129-134. (Pubitemid 29045185)
14. Pierce LM, Sivaraman L, Chang W, Lum A, Donlon T, Seifried A, Wilkens LR, Lau AF, Le Marchand L. Relationships of TP53 Codon 72 and HRAS1 Polymorphisms with Lung Cancer Risk in an Ethnically Diverse Population. Cancer Epidemiol Biomark Prev 2000; 9:1199-1204.
15. Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003; 18:377-385. (Pubitemid 36850206)
16. Lee JM, Shun CT, Wu MT, Chen YY, Yang SY, Hung HI, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer. Mutat Res 2006; 594:181-188. (Pubitemid 43170998)
17. Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, Giovannucci EL, Hunter DJ. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer 2006; 119:1863-1868. (Pubitemid 44356844)
18. Tommiska J, Eerola H, Heinonen M, Salonen L, Kaare M, Tallila J, Ristimaki A, von Smitten K, Aittomaki K, Heikkila P, Blomqvist C, Nevanlinna H. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin Cancer Res 2005; 11:5098-5103. (Pubitemid 41003693)
19. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 2002; 179:175-183. (Pubitemid 34215109)
20. Koushik A, Platt RW, Franco EL. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 2004; 13:11-22. (Pubitemid 38116615)
21. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19:1092-1100. (Pubitemid 29046852)
22. Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 1995; 16:2205-2208.
23. Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S, Saisho H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 1996; 17:261-264. (Pubitemid 26091303)
24. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998; 393:229-234. (Pubitemid 28261713)
25. Tenti P, Vesentini N, Rondo-Spaudo M, Zappatore R, Migliora P, Carnevali L, Ranzani GN. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy. Cancer Epidemiol Biomark Prev 2000; 9:435-438. (Pubitemid 30265788)
26. Ministerio del Poder Popular para la Salud. República Bolivariana de Venezuela. Anuario de Mortalidad 2005. 2006; http:// www.mpps.gob.ve.
27. Wu X, Zhao H, Amos CI, Shete S, Makan N, WK Hong, Kadlubar FF, Spitz MR. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 2002; 94:681-690. (Pubitemid 34552489)
28. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230:1350-1354. (Pubitemid 16105164)
29. Schenieder S, Roessli D, Excoffier L. Arlequin ver. 2.000: A software for population genetics analysis. Genetics ad Biometry Laboratory, University of Geneva, Switzerland (2000).
30. Dutt A, Beroukhim R. Single nucleotide polymorphism array analysis of cancer. Curr Opin Oncol 2007; 19:43-49. (Pubitemid 44885599)
31. Pérez-Pérez GI, Bosques-Padilla FJ, Crosatti ML, Tijerina-Menchaca R, Garza-González E. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol 2005; 40:56-60.
32. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML, Wu XT. p53 codon 72 polymorphism and gastric cancer: A meta-analysis of the literature. Int J Cancer 2007; 121:1481-1486. (Pubitemid 47328706)
33. Mammano E, Belluco C, Bonafé M, Olivieri F, Mugianesi E, Barbi C, Mishto M, Cosci M, Franceschi C, Lise M, Nitti D. Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression. Eur J Surg Oncol. 2009; 35: 415-419.
34. Chung WC, Lee KM, Lee BI, Chun JS, Lee SY, Chang UI, Park SH, Yang JM, Choi KY, Chung IS. p53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med 2006; 21:28-32. (Pubitemid 43732763)